Bioventus Inc.BVSNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank100
5Y CAGR+15.3%
Studio
Year-over-Year Change

Free cash flow yield

5Y CAGR
+15.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
202514.41%+161.6%
20245.51%+127.8%
20232.42%+125.8%
2022-9.37%-3038.9%
20210.32%-95.5%
20207.06%+138.1%
20192.97%-17.3%
20183.58%-
20170.00%-
20160.00%-